Ocular-motor conduction dynamics and variability in multiple sclerosis–related internuclear ophthalmoparesis: A randomized dalfampridine trial
Multiple Sclerosis Journal – Experimental, Translational and Clinical · 2026-07 · 12 (3)
DOI: 10.1177/20552173261464348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal – Experimental, Translational and Clinical, online erschienen am 07.07.2026. Verfasst von Alessandro Serra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Daroff-Dell'Osso Ocular Motility Laboratory and Department of Neurology, VA Multiple Sclerosis Center of Excellence Regional Program, Cleveland, OH, …. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Rehabilitation Research and Development Service.
Abstract (Originalsprache)
Background
Internuclear ophthalmoparesis (INO) in multiple sclerosis (MS) reflects impaired signal transmission within the medial longitudinal fasciculus (MLF). Increased pulse size ratio (PSR) and prolonged pulse time delay (PTD) quantify interocular velocity asymmetry and transmission timing.
Objective
To characterize PSR and PTD during ocular-motor fatigue in MS-related INO and the effects of dalfampridine.
Methods
In a randomized, double-blind, placebo-controlled crossover trial, 19 participants with MS-related INO underwent eye-movement recordings during a 10-min saccadic task. PSR and PTD were analyzed at saccade, INO, and participant levels.
Results
23,904 INO and 2408 control paired saccades were analyzed. In INO, PTD was prolonged and PSR elevated, with a positive correlation. Dalfampridine did not significantly improve prespecified ocular-motor outcomes, including mean PSR, mean PTD, or early–late fatigue measures. Responses were heterogeneous. Exploratory analyses showed dynamic PSR and PTD fluctuations, with a trend toward reduced PSR variability during dalfampridine. Greater trough PTD variability was associated with larger PTD shortening during dalfampridine, but not placebo.
Conclusions
Dalfampridine did not significantly improve prespecified ocular-motor outcomes. PSR and PTD capture complementary aspects of internuclear signal transmission, with ocular-motor fatigue reflecting dynamic instability. PTD variability is associated with variation in response to dalfampridine, supporting further study as a tract-specific biomarker.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Daroff-Dell'Osso Ocular Motility Laboratory and Department of Neurology, VA Multiple Sclerosis Center of Excellence Regional Program, Cleveland, OH, USA.
- MS & Neuroimmunology Program, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
- School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
- Department of Medical, Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, Catania, Italy.
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.
- Brain Plasticity and NeuroRecovery Laboratory, Cleveland VA Medical Center, Cleveland, OH, USA.
ORCID-Profile: Alessandro Serra, Clara Chisari, Hesham Abboud, Mark F Walker
Förderung
- Rehabilitation Research and Development Service
Zitieren
APA
Serra, A., Chisari, C., Jacobs, J. B., Skelly, M. M., McCabe, J., Abboud, H., & Walker, M. F. (2026). Ocular-motor conduction dynamics and variability in multiple sclerosis–related internuclear ophthalmoparesis: A randomized dalfampridine trial. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 12(3). https://doi.org/10.1177/20552173261464348
Vancouver
Serra A, Chisari C, Jacobs JB, Skelly MM, McCabe J, Abboud H, et al. Ocular-motor conduction dynamics and variability in multiple sclerosis–related internuclear ophthalmoparesis: A randomized dalfampridine trial. Multiple Sclerosis Journal – Experimental, Translational and Clinical. 2026;12(3). doi:10.1177/20552173261464348
BibTeX
@article{Serra2026,
author = {Serra, Alessandro and Chisari, Clara and Jacobs, Jonathan B and Skelly, Margaret M and McCabe, Jessica and Abboud, Hesham and Walker, Mark F},
title = {Ocular-motor conduction dynamics and variability in multiple sclerosis–related internuclear ophthalmoparesis: A randomized dalfampridine trial},
journal = {Multiple Sclerosis Journal – Experimental, Translational and Clinical},
year = {2026},
volume = {12},
number = {3},
doi = {10.1177/20552173261464348}
}
EUVIMED